|
|
Volumn 98, Issue 24, 2006, Pages 1826-1827
|
|
Re: Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer [3]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
AGE DISTRIBUTION;
AGED;
ANAMNESIS;
ANEMIA;
BREAST CANCER;
CANCER SCREENING;
CANCER STAGING;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CULTURAL FACTOR;
DEEP VEIN THROMBOSIS;
DISCRIMINANT ANALYSIS;
DRUG FEVER;
DRUG SURVEILLANCE PROGRAM;
ELECTROLYTE DISTURBANCE;
FEMALE;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HOSPITAL COST;
HUMAN;
INFECTION;
LETTER;
MAJOR CLINICAL STUDY;
MASTECTOMY;
NEUTROPENIA;
PATHOPHYSIOLOGY;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROPORTIONAL HAZARDS MODEL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
STATISTICAL MODEL;
SURGICAL TECHNIQUE;
THROMBOCYTOPENIA;
THROMBOPHLEBITIS;
UNSPECIFIED SIDE EFFECT;
AGED;
ANEMIA;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
FEMALE;
FEVER;
HEALTH CARE COSTS;
HOSPITAL COSTS;
HUMANS;
INFECTION;
ITALY;
MIDDLE AGED;
NEUTROPENIA;
PATIENT ADMISSION;
POPULATION SURVEILLANCE;
THROMBOCYTOPENIA;
|
|
EID: 33845889718
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djj492 Document Type: Letter |
|
Times cited : (9)
|
|
References (3)
|
